SCHEMBL6902224

SCHEMBL6902224

O=C(O)c1c(N2CCOCC2)c2ccccc2n1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 12/20 0.67
PIK3C2B O00750 1/20 0.51
ABCB11 O95342 1/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
MAPT P10636 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48
CYP2C19 P33261 1/20 0.48
PRKDC P78527 1/20 0.47
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899592 0.85 CCR2 (0.52) CCR2PIK3C2BABCB11ALDH1A1LMNA
SCHEMBL30449382 0.83 HDAC6 (0.61)
SCHEMBL5219974 0.82 CCR2 (0.63) CCR2PIK3C2BABCB11ALDH1A1LMNA
SCHEMBL6599738 0.81 CCR2 (1.00) CCR2ABCB11ALDH1A1LMNACYP1A2
SCHEMBL6302591 0.79 CCR2 (1.00) CCR2ABCB11ALDH1A1LMNACYP1A2
SCHEMBL5213947 0.78 CCR2 (0.77) CCR2ABCB11ALDH1A1LMNACYP1A2
SCHEMBL6307042 0.78 CCR2 (0.77) CCR2ABCB11ALDH1A1LMNACYP1A2
SCHEMBL6307834 0.77 CCR2 (0.84) CCR2ABCB11ALDH1A1LMNACYP1A2
SCHEMBL5221748 0.77 CCR2 (0.74) CCR2ABCB11ALDH1A1LMNACYP1A2
SCHEMBL5214630 0.75 CCR2 (0.80) CCR2ABCB11ALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6833387-B1 3-substituted indoles; inhibition of monocyte chemoattractant protein-1 and/or RANTES induced chemotaxis; inflammatory diseases ASTRAZENECA AB (SE) 2004-12-21 US disclosed